Heartflow

HeartFlow is a medical technology company that advances the diagnosis and management of coronary artery disease. Its flagship product is the HeartFlow FFR CT Analysis, a non-invasive cardiac test that generates a 3D model of a patient's coronary arteries to indicate how blockages affect blood flow. The integrated solution also includes the RoadMap Analysis to help clinicians identify stenoses and Plaque Analysis to characterize and quantify coronary atherosclerosis.

The company utilizes artificial intelligence and deep learning to support its cardiac care solutions across the CCTA pathway. Its technology processes medical imaging data to assess blood flow and assist clinicians in patient evaluation. HeartFlow's products are cleared for use in the United States, the United Kingdom, Europe, Japan, and Canada, and the technology has been utilized for more than 750,000 patients globally. The publicly traded company maintains a growing product pipeline and team focused on precision heart care.